| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.61 ▲ +1.33% | Yesterday | $2.57 ▼ -0.56% | Tomorrow's Connect Biopharma Holdings Limited Ordinary Shares (CNTB) setup is anchored to $2.58 and targets $2.61 (+1.33%). The near-term read is upside; watch $2.66 / $2.50 because daily realized volatility is about 6.84%. |
Tomorrow's Connect Biopharma Holdings Limited Ordinary Shares (CNTB) setup is anchored to $2.58 and targets $2.61 (+1.33%). The near-term read is upside; watch $2.66 / $2.50 because daily realized volatility is about 6.84%. | ||||
| Week | $2.69 ▲ +4.12% | Last Week | $2.54 ▼ -1.73% | The 7-day Connect Biopharma Holdings Limited Ordinary Shares model moves from $2.54 to $2.69 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.66 / $2.50 matter more than a single tick. |
The 7-day Connect Biopharma Holdings Limited Ordinary Shares model moves from $2.54 to $2.69 (+4.12%). It gives upside momentum context for this stock, so breaks around $2.66 / $2.50 matter more than a single tick. | ||||
| Month | $2.81 ▲ +8.79% | Last Month | $2.48 ▼ -3.69% | The 1-month Connect Biopharma Holdings Limited Ordinary Shares target is $2.81 (+8.79%), compared with the live reference near $2.58. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Connect Biopharma Holdings Limited Ordinary Shares target is $2.81 (+8.79%), compared with the live reference near $2.58. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.99 ▲ +15.77% | Last Year | $2.41 ▼ -6.62% | The 1-year Connect Biopharma Holdings Limited Ordinary Shares scenario points to $2.99 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Connect Biopharma Holdings Limited Ordinary Shares scenario points to $2.99 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $3.41 ▲ +32.14% | 5 Years Ago | $2.23 ▼ -13.50% | The 5-year Connect Biopharma Holdings Limited Ordinary Shares view is $3.41 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Connect Biopharma Holdings Limited Ordinary Shares view is $3.41 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $2.58 | Mid |
| Daily Change | -3.73% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $2.58 | Daily Change | -3.73% |
| Market Cap | $145.82M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.